Gary Titus
2018
In 2018, Gary Titus earned a total compensation of $3.5M as Former Chief Financial Officer at UroGen Pharma Ltd., a 224% increase compared to previous year.
Compensation breakdown
| Option Awards | $695,835 |
|---|---|
| Salary | $175,000 |
| Other | $2,616,274 |
| Total | $3,487,109 |
Titus received $2.6M in other compensation, accounting for 75% of the total pay in 2018.
Titus also received $695.8K in option awards and $175K in salary.
Rankings
In 2018, Gary Titus' compensation ranked 3,260th out of 14,244 executives tracked by ExecPay. In other words, Titus earned more than 77.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,260 out of 14,244 | 77th |
Division Manufacturing | 1,206 out of 5,759 | 79th |
Major group Chemicals And Allied Products | 418 out of 2,122 | 80th |
Industry group Drugs | 346 out of 1,811 | 81st |
Industry Pharmaceutical Preparations | 265 out of 1,385 | 81st |
Source: SEC filing on April 26, 2019.
Titus' colleagues
We found six more compensation records of executives who worked with Gary Titus at UroGen Pharma Ltd. in 2018.
2018
Ron Bentsur
UroGen Pharma Ltd.
Chief Executive Officer
2018
Stephen Mullennix
UroGen Pharma Ltd.
Chief Financial Officer
2018
Gil Hakim
UroGen Pharma Ltd.
Former President
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Mark Schoenberg
UroGen Pharma Ltd.